| Ytd | 1.42% | |
| 1y | -2.77% |
| Open | 16.90 | Prev Close | 16.88 | Low | 16.83 | High | 17.23 | Mkt Cap | 6.03B |
| Vol | 7.92M | Avg Vol | 3.84M | EPS | -0.26 | P/E | N/A | Forward P/E | 245.36 |
| Beta | 0.84 | Short Ratio | 5.29 | Inst. Own | 115.34% | Dividend | 0.96 | Div Yield | 5.63 |
| Ex Div Date | 08-11 | Earning | 10-29 | 50-d Avg | 18.98 | 200-d Avg | 18.79 | 1yr Est | 21.42 |
NASHVILLE, Tenn., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) t
Pensionfund PDN acquired a new position in Healthcare Realty Trust Incorporated (NYSE: HR) during th
Corient Private Wealth LP bought a new stake in Healthcare Realty Trust Incorporated (NYSE: HR) in t
State Street Corp trimmed its stake in shares of Healthcare Realty Trust Incorporated (NYSE: HR) by
The heavy selling pressure might have exhausted for Healthcare Realty Trust (HR) as it is technicall
[url="]PureTech Health plc[/url] (LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biothera
Jefferies analyst Joe Dickstein assumes Healthcare Realty Trust (NYSE:HR) with a Hold rating and
Positive results from the DESTINY-Lung04 Phase III trial showed AstraZeneca and Daiichi Sankyo's ENH
Summit Therapeutics Inc. (NASDAQ: SMMT) today noted that its partner Akeso Inc. [url="]announced[/ur
Healthcare Realty Trust (HR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism
AstraZeneca's ETCAMAHÂ (camizestrant) in combination with a cyclin-dependent kinase (CDK) 4/6 inhibi
Wells Fargo analyst John Kilichowski maintains Healthcare Realty Trust (NYSE:HR) with a Equal-Wei
Healthcare Realty Trust (HR) appears to have found support after losing some value lately, as indica
Healthcare Realty Trust (HR) has become technically an oversold stock now, which implies exhaustion
RBC Capital analyst Michael Carroll maintains Healthcare Realty Trust (NYSE:HR) with a Sector Per
Healthcare Realty Trust NYSE: HR reported second-quarter results marked by higher occupancy, leasing
Healthcare Realty Trust Incorporated (HR) Q2 2026 Earnings Call Transcript
Cantor Fitzgerald analyst Richard Anderson maintains Healthcare Realty Trust (NYSE:HR) with a Ove
Healthcare Realty Trust (HR) came out with quarterly funds from operations (FFO) of $0.41 per share,
Healthcare Realty Trust (NYSE:HR) reported quarterly earnings of $0.41 per share which beat the anal
Healthcare Realty Trust (NYSE:HR) raises FY2026 FFO guidance from $1.59-$1.65 to $1.62-$1.66 vs $1.6
NASHVILLE, Tenn., July 30, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) t
JP Morgan analyst Michael Mueller maintains Healthcare Realty Trust (NYSE:HR) with a Neutral and
NASHVILLE, Tenn., July 07, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) t
Raymond James analyst David Rodgers reinstates Healthcare Realty Trust (NYSE:HR) with a Outperfor
enGene Therapeutics Inc. (Nasdaq: ENGN, âenGeneâ or the âCompanyâ), a clinical-stage, non-vi
EXPD, VNCE, UCTT, PRG and TNET have been added to the Zacks Rank #1 (Strong Buy) List on June 8, 202
Further positive results from the Phase III SERENA-6 trial showed AstraZeneca's camizestrant plus a
Wells Fargo analyst John Kilichowski maintains Healthcare Realty Trust (NYSE:HR) with a Equal-Wei
RBC Capital analyst Michael Carroll maintains Healthcare Realty Trust (NYSE:HR) with a Sector Per
Scotiabank analyst Nicholas Yulico maintains Healthcare Realty Trust (NYSE:HR) with a Sector Outp
Citigroup analyst Nick Joseph maintains Healthcare Realty Trust (NYSE:HR) with a Neutral and rais
Cantor Fitzgerald analyst Richard Anderson maintains Healthcare Realty Trust (NYSE:HR) with a Ove
Healthcare Realty Trust Incorporated (NYSE:HR) ("Healthcare Realty") today announced that it
Healthcare Realty Trust (NYSE:HR) raises FY2026 FFO guidance from $1.58-$1.64 to $1.59-$1.65 vs $0.2
Healthcare Realty Trust (NYSE:HR) reported quarterly earnings of $0.41 per share. This is a 5.13 per
UBS initiates coverage on Healthcare Realty Trust (NYSE:HR) with a Neutral rating and announces Pr
Cantor Fitzgerald analyst Richard Anderson maintains Healthcare Realty Trust (NYSE:HR) with a Ove
Healthcare Realty Trust (NYSE:HR) reported quarterly earnings of $0.40 per share. This is unchanged
Healthcare Realty Trust Incorporated (NYSE:HR) ("Healthcare Realty" or the "Company"
Wells Fargo analyst John Kilichowski maintains Healthcare Realty Trust (NYSE:HR) with a Equal-Wei
Healthcare Realty Trust (NYSE:HR) reported quarterly sales of $297.765 million which beat the analys
Wells Fargo analyst John Kilichowski upgrades Healthcare Realty Trust (NYSE:HR) from Underweight